Астеллас препараты

Astellas Pharma - 15 Acquisitions - Tracxn

Japan's Astellas sees cancer drug fueling 29% p...

Daiichi Sankyo buys three drugs from Astellas P...

Astellas Pharma's Breakthrough Drug Approved By...

Astellas to buy Iveric Bio for $5.9 billion to ...

For pharmaceutical company Astellas, the Nether...

Astellas Pharma Projects :: Photos, videos, log...

Astellas, University of Tokyo extend partnershi...

Astellas Is Considering Selling Europe Assets t...

Astellas Pharma to build a new €330M facility i...

Astellas Home page | Astellas Pharma Inc.

Astellas licenses 4DMT’s AAV vector for ophthal...

About | Astellas Pharma Ltd

Astellas Sues Over New Myrbetriq Patent to Reca...

Astellas Offloads 5 Legacy Products to Germany’...

Astellas Pharma on the Forbes Top Regarded Comp...

Astellas Pharma - Global Web Site on Behance

Astellas introduces sustainable community initi...

Astellas Pharma US (@AstellasUS) / Twitter

Astellas' Prostate Cancer Drug Available In Jap...

Astellas doses first subject in menopausal VMS ...

FDA Grants Full Approval for Astellas Pharma's ...

China Formally Arrests Japanese Employee of Dru...

Astellas

Astellas Pharmaceuticals Establishes Open Innov...

Astellas buys eye gene therapy biotech Quethera...

About Astellas | Astellas Pharma Canada, Inc.

Pharmaceutical Technology

Home | Astellas Pharma Canada, Inc.

#LeaveRussia: Astellas Pharma is Temporarily Pa...

Astellas Pharma Inc. (4503N.MX) stock price, ne...

Astellas Pharma

About Astellas | Astellas Pharma US, Inc.

Asia Business Daily on Twitter: "Astellas Pharm...

FDA rejects Astellas' zolbetuximab for manufact...